Skip to main content
Oxford University Hospitals NHS Foundation Trust
Research and Development

Coronavirus / COVID-19

If you have a new continuous cough and/or high temperaturedo not come to our hospitalsFollow the national advice and stay at home for seven days

Important information about our services and restrictions on visiting our hospitals can be found in the COVID-19 section.

This site is best viewed with a modern browser. You appear to be using an old version of Internet Explorer.

Medicines and Healthcare products Regulatory Agency (MHRA)

All studies falling into the category of Clinical Trials will require authorisation by the Medicines and Healthcare products Regulatory Agency (MHRA).

The EU Clinical Trials Directive (EUCTD) is a legal document which sets out how clinical trials investigating the safety or efficacy of a medicinal product in humans must be conducted.

It was implemented into UK law in May 2004, as the Medicines for Human Use (Clinical Trials) Regulations 2004, and has since been amended (2006a, 2006b, 2008).

For details on making submissions to MHRA, and the fees, please visit: